Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLoose stools and diarrhoea are among the more common gut-related side effects reported at the 7.5mg Mounjaro dose, and most people find they settle within a couple of weeks as the body adjusts. Tirzepatide slows gastric emptying and changes how the digestive system processes food, which is why the bowel often reacts when the dose steps up. That said, not everyone experiences this, and for those who do, the severity varies considerably. These are prescription-only medicines that require clinical assessment before they are prescribed, and a prescriber is best placed to help if symptoms feel unmanageable.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works on two gut-hormone receptors (GIP and GLP-1) and one of its most consistent effects is slowing the rate at which the stomach empties into the small intestine. At lower doses the gut has usually had several weeks to adapt; the move to 7.5mg asks it to adjust again. For some people that recalibration is smooth. For others, the bowel temporarily speeds up rather than slows down, producing looser stools or outright diarrhoea.
The NHS medicines information page for tirzepatide lists diarrhoea as a common side effect, meaning it affects roughly one in ten or more people across the dose range. The 7.5ml Mounjaro pen delivers this step-up dose, and the pattern of symptoms peaking in the days after a dose change then gradually easing is well recognised. If you want a fuller picture of how the 5mg stage tends to compare, the guide to diarrhoea on Mounjaro 5mg covers that period in detail.
Food choices can also play a role. High-fat, greasy meals sit poorly with delayed gastric emptying and are more likely to trigger gut symptoms. Eating smaller portions, cutting back on ultra-processed foods, and staying well hydrated all help the bowel settle faster. These aren't curative steps, but they make the adjustment window more manageable for most people.
Hydration is the priority. Diarrhoea loses fluid quickly, and the risk of becoming dehydrated is real, especially if appetite is already reduced by tirzepatide. Sipping water steadily through the day, rather than drinking large amounts at once, keeps fluid levels steadier. Oral rehydration sachets (available over the counter) can help replace electrolytes if stools are very loose.
Plain, low-fat foods are your best allies: rice, plain chicken, cooked vegetables, toast. Caffeine, alcohol and high-fibre foods can aggravate an already unsettled gut, so it's worth limiting them temporarily. Some people find that taking their injection on a day when they can eat lightly and rest helps reduce the peak of symptoms.
Anti-diarrhoeal medicines such as loperamide can be used short-term, but checking with a pharmacist or your prescriber first is sensible, particularly if you have any other conditions or take other medicines. The Mounjaro 7.5mg overview sets out more of the context around this dose, including what the titration schedule is designed to do. For the specifics of the pen itself, the 7.5mg pen guide covers injection technique and storage.
If you're feeling frustrated that symptoms have returned just as you thought you'd found your feet on Mounjaro, that's completely understandable, it can feel like one step forward, one step back. For many people this phase does pass.
Most diarrhoea on Mounjaro 7.5mg is an inconvenience, not a danger. But some presentations warrant medical attention promptly, and knowing the difference matters.
Seek urgent help if you have diarrhoea that has lasted more than 48 hours without easing, if you have signs of dehydration (significant thirst, dark urine, dizziness, feeling faint), or if you're unable to keep fluids down alongside the diarrhoea. Kidney function can be affected by persistent dehydration, and this is documented in tirzepatide's prescribing information.
Separately, and critically: severe, persistent stomach pain that radiates to the back, with or without vomiting, is not a gut-adjustment symptom. This combination can indicate pancreatitis, which is a rare but serious risk with this class of medicine. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a known, infrequent but potentially serious side effect of GLP-1 medicines. Do not wait to see if it passes, call NHS 111 or go to A&E.
Blood in your stools, signs of an allergic reaction (swelling, rash, difficulty breathing), or any symptom that feels out of proportion to what you've experienced at previous doses are also reasons to contact a clinician the same day. Your GP, NHS 111, or our team are all appropriate first contacts depending on the severity.
In most cases, no. A week of unsettled bowel habits after a dose increase does not mean 7.5mg is wrong for you, and stopping or reducing without prescriber input is rarely the right call. The titration schedule exists precisely because the body needs time to adjust, and most people do adjust.
Where things are different is if diarrhoea is persistent, severe, or affecting your ability to stay hydrated. In those situations a prescriber may choose to slow the titration, explore dietary adjustments more formally, or consider whether a different approach suits you better. None of those decisions should be made alone. The full Mounjaro information page explains the broader treatment journey, and if you're considering starting or reviewing your treatment, the consultation page is where our prescribers discuss suitability and any side effects in detail before anything is prescribed.
For context on how the 2.5mg starting period compares, the guide to diarrhoea on Mounjaro 2.5mg is worth reading alongside this page. And if you have broader questions about the dose, the FAQs cover many of the things our prescribers hear regularly. The weight loss treatment overview also sets out where tirzepatide fits within the wider options available.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.